Hyperthyroidism Clinical Trials

8 recruitingLast updated: May 13, 2026

There are 8 actively recruiting hyperthyroidism clinical trials across 4 countries. Studies span Phase 2, Phase 1, Phase 3. Top locations include Beijing, China, Bethesda, Maryland, United States, Bologna, BO, Italy. Updated daily from ClinicalTrials.gov.


Hyperthyroidism Trials at a Glance

8 actively recruiting trials for hyperthyroidism are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Beijing, Bethesda, and Bologna. Lead sponsors running hyperthyroidism studies include IRCCS Azienda Ospedaliero-Universitaria di Bologna, Jan Calissendorff, and Chinese PLA General Hospital.

Browse hyperthyroidism trials by phase

Treatments under study

About Hyperthyroidism Clinical Trials

Looking for clinical trials for Hyperthyroidism? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hyperthyroidism trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hyperthyroidism clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Natural History of Thyroid Function Disorders

HypothyroidismHyperthyroidismGrave's Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2,500 enrolled1 locationNCT00001159
Recruiting

Efficacy of Thermal Ablation Combined With Antithyroid Drugs in the Treatment of Primary Hyperthyroidism

Efficacy and SafetyHyperthyroidism/ThyrotoxicosisComplication Rate+1 more
Chinese PLA General Hospital454 enrolled1 locationNCT07557810
Recruiting
Phase 3

Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter

Hyperthyroidism
Jan Calissendorff182 enrolled1 locationNCT04856488
Recruiting
Phase 1Phase 2

Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease

Malignant TumorHyperthyroidism, AutoimmuneCardiovascular Abnormalities
Peking Union Medical College Hospital600 enrolled1 locationNCT07400224
Recruiting
Phase 2

Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease

Graves DiseaseHyperthyroidism
Northwell Health30 enrolled1 locationNCT07369063
Recruiting

Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft

Kidney TransplantKidney DiseasesHyperthyroidism
IRCCS Azienda Ospedaliero-Universitaria di Bologna100 enrolled1 locationNCT06794203
Recruiting

Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology

Thyroid CarcinomaHypothyroidismThyroid Nodule \(Benign\)+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna5,850 enrolled1 locationNCT06779747
Recruiting

A Clinical Study of Hyperthyroidism in Children

Hyperthyroidism
Shengjing Hospital1,000 enrolled1 locationNCT06570967